Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
63.1M
-
Shares change
-
-283K
-
Total reported value, excl. options
-
$220M
-
Value change
-
-$9.65M
-
Number of buys
-
45
-
Number of sells
-
-70
-
Price
-
$3.48
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q4 2019
137 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q4 2019.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.1M shares
of 374M outstanding shares and own 16.85% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (6.48M shares), Russell Investments Group, Ltd. (5.86M shares), Neuberger Berman Group LLC (5.67M shares), BlackRock Inc. (5.29M shares), VANGUARD GROUP INC (4.41M shares), Levin Easterly Partners LLC (4.38M shares), Indaba Capital Management, L.P. (3.32M shares), Partner Fund Management, L.P. (3.23M shares), RENAISSANCE TECHNOLOGIES LLC (2.79M shares), and ACADIAN ASSET MANAGEMENT LLC (1.69M shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.